These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6389104)

  • 1. Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.
    Roth RA; Mesirow ML; Yokono K; Baba S
    Endocr Res; 1984; 10(2):101-12. PubMed ID: 6389104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of insulin degradation by insulin-like growth factors.
    Misbin RI; Almira EC; Duckworth WC; Mehl TD
    Endocrinology; 1983 Oct; 113(4):1525-7. PubMed ID: 6352249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
    Misbin RI; Almira EC
    Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
    Yonezawa K; Yokono K; Yaso S; Hari J; Amano K; Kawase Y; Sakamoto T; Shii K; Imamura Y; Baba S
    Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 1997 Feb; 46(2):197-203. PubMed ID: 9000694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of insulin-degrading enzyme from pig skeletal muscle.
    Yokono K; Imamura Y; Shii K; Sakai H; Baba S
    Endocrinology; 1981 Apr; 108(4):1527-32. PubMed ID: 7009152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of residues in the insulin molecule important for binding to insulin-degrading enzyme.
    Affholter JA; Cascieri MA; Bayne ML; Brange J; Casaretto M; Roth RA
    Biochemistry; 1990 Aug; 29(33):7727-33. PubMed ID: 2271531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Insulin-like substance and insulin-degrading complex in hemolysates of human erythrocytes].
    Matuliavichius VA; Vareĭkis EI; Lashas LV
    Biokhimiia; 1986 Feb; 51(2):278-84. PubMed ID: 3516229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent linkage of 125I-insulin to a cytosolic insulin-degrading enzyme.
    Shii K; Baba S; Yokono K; Roth RA
    J Biol Chem; 1985 Jun; 260(11):6503-6. PubMed ID: 3888982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding and degradation of insulin-like growth factors I and II by rat kidney membrane.
    Bhaumick B; Bala RM
    Endocrinology; 1987 Apr; 120(4):1439-48. PubMed ID: 3549261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of a mutant insulin by a receptor-mediated process and an insulin degrading enzyme.
    Kobayashi M; Iwasaki M; Watanabe N; Ishibashi O; Takata Y; Haruta T; Sasaoka T; Shigeta Y; Inouye K
    Diabetes Res Clin Pract; 1986; 2(5):257-62. PubMed ID: 3536368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III.
    Ding L; Becker AB; Suzuki A; Roth RA
    J Biol Chem; 1992 Feb; 267(4):2414-20. PubMed ID: 1733942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetic studies of insulin degrading enzyme in cultured human lymphocytes].
    Yaso S
    Nihon Naibunpi Gakkai Zasshi; 1988 Apr; 64(4):289-302. PubMed ID: 3042472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGF-II binding on human lymphoid cells: demonstration of a common high affinity receptor for insulin like peptides.
    Hintz RL; Thorsson AV; Enberg G; Hall K
    Biochem Biophys Res Commun; 1984 Feb; 118(3):774-82. PubMed ID: 6322765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Degradation of the four monoiodoinsulin isomers by the insulin protease of rat liver.
    Brush JS; Sonne O; Gliemann J
    Biochim Biophys Acta; 1983 Jun; 757(3):269-73. PubMed ID: 6342683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
    Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
    Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. One for all and all for one: RB defends the cell while IDE, PTEN and IGFBP-7 antagonize insulin and IGFs to protect RB.
    Radulescu RT
    Med Hypotheses; 2007; 69(5):1018-20. PubMed ID: 17475416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin.
    Garcia JV; Gehm BD; Rosner MR
    J Cell Biol; 1989 Sep; 109(3):1301-7. PubMed ID: 2670957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of an intracellular insulin-degrading enzyme in human erythrocytes.
    Gambhir KK; Nerurkar SG
    Biochem Med Metab Biol; 1988 Jun; 39(3):284-9. PubMed ID: 3293635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid molecules containing the B-domain of insulin-like growth factor I are recognized by carrier proteins of the growth factor.
    De Vroede MA; Rechler MM; Nissley SP; Joshi S; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1985 May; 82(9):3010-4. PubMed ID: 2581261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.